medigraphic.com
ISSN 1729-6935 (Electronic)
16 de abril

2022, Number 285

<< Back Next >>

16 de abril 2022; 61 (285)

Clinical-epidemiological behavior of post-COVID-19 syndrome in patients at Andrés Ortiz Polyclinic, 2021

Silva-Rodríguez S, Núñez-Blanco PP, Rodríguez-Arévalo L, Rodríguez-Moreno VM, Pérez-Sanz D

Language: Spanish
References: 21
Page: 1-5
PDF size: 292.07 Kb.


ABSTRACT

Introduction: post-COVID-19 syndrome is the set of signs and symptoms that develop during or after an infection compatible with COVID-19, that persist for more than 12 weeks and are not explained by an alternative diagnosis.
Objective: to characterize the clinical-epidemiological behavior of the post-COVID-19 syndrome in patients at the Andrés Ortiz Polyclinic.
Method: a descriptive and cross-sectional observational study was carried out from October to December 2021, in a population of 51 subjects that was studied in its entirety. The analysis was descriptive.
Results: patients with 50-59 years (n = 20; 39.2%), female (n = 32; 62.7%) predominated. The most frequently affected organ system was the respiratory (n = 19; 37.2%), while the symptoms were: chronic fatigue (n = 15; 29.4%), shortness of breath (n = 11; 21.5%) and cough (n = 8, 15.6%). Among the patients with respiratory (n = 30), cardiovascular (n = 24) and neurological (n = 10) diseases, the most frequent were, respectively: pulmonary fibrosis (n = 17; 56.7%), cardiac arrhythmias (n = 11; 45.8%) and peripheral neuropathies (n = 5; 50%).
Conclusions: post-COVID-19 syndrome occurred mainly between the ages of 50 and 59, in female patients, with symptoms of chronic fatigue, shortness of breath and cough, as well as pulmonary fibrosis, cardiac arrhythmias and peripheral neuropathies as main comorbidities.


REFERENCES

  1. Cui J, Li F, Shi ZL. Origin and evolutionof pathogenic coronaviruses.Nat Rev Microbiol [Internet]. 2019[citado 18/05/2022];17:181-92. Disponibleen https://www.scirp.org.natrevmicrobiol/article/view

  2. Gutiérrez Bautista D, MosquedaMartínez EE, Joaquin VilchisH, Morales Fernández JA, CruzSalgado AX; Chávez Aguilar JE, etal. Efectos a largo plazo de la COVID-19: una revisión de la literatura.Act Med [Internet]. 2021 [citado18/05/2022];19(3):421-428. Disponibleen https://www.scielo.org.mx.actmed.

  3. NICE panel expert. COVID-19 rapidguideline: managing the longtermeffects of COVID-19. [Internet].2020 [citado 18/05/2022];18(3):23-31. Disponible en https://www.nice.org.uk.nicepanelexpert.

  4. Bouza E, Cantón Moreno R, DeLucas Ramos P, García-Botella A,García-Lledó A, Gómez-Pavón J, etal. Síndrome post-COVID: Un documentode reflexión y opinión. RevEsp Quimioter [Internet]. 2021 [citado18/05/2022];34(4):272-273. Disponiblehttps://www.ncbi.nlm.nih.gov.doi:10.37201/req/023.2021

  5. Tenforde M, Kim S, Lindsell C, BilligRose E, Shapiro N, Files D, et al.Symptom duration and risk factorsfor delayed return to usual healthamong outpatients with COVID-19in a Multistate Health Care SystemsNetworkUnited States. MMWR MorbMortal Wkly Rep [Internet]. 2020[citado18/05/2022];69(30):993-98.Disponible en https://www.pubmed.ncbi.nlm.nih.gov.mwtenforde2020

  6. Espinosa-Brito, Alfredo. A propósitode la definición clínica oficial de laenfermedad pos-COVID por la OMS.Medisur [Internet]. 2022 [citado18/05/2022];20(1):14. Disponible enhttps://www.medisur.sld.cu/index/php/medisur/article/view/5337

  7. Evans R, McAuley H, Harrison E,Shikotra A, Singapuri A, Sereno Met al. Physical, cognitive and mentalhealth impacts of COVID-19following hospitalization-a multi-centre prospective cohort study.Lancet Respir Med [Internet]. 2021[citado 18/05/2022];19(1):11-13. Disponible en https://doi.org/10.1101/2021.03.22.21254057

  8. NIHR: Living with Covid19 - Secondreview. [Internet]. 2021 [citado18/05/2022];18(1):13. Disponibleen https://evidence.nihr.ac.uk.doi:10.3310/themereview_41169

  9. Prieto MA, Prieto O, Castro HM.Covid prolongado: estudio de cohortetransversal. Rev Fac Cien MedUniv Nac Cordoba [Internet]. 2021[citado 18/05/2022];78(1):33–36. Disponible en https://revistas.unc.edu.ar.estudiodecohortetransversal

  10. Dore GJ, Cysique L, Wilhelm KA, AndresenD, Tonga K, Stone E, et al. Persistentsymptoms up to 4 months after communityand hospital- managed SARS-CoV-2infection. Med Journal Australia [Internet].2020 [citado18/05/2022];21(2):5-7.Disponible en https://pubmed.ncbi.nlm.nih.gov.doi:10.5694/mja2.59963

  11. Hierrezuelo Rojas N, Cardero CastiloF, Carbó Cisnero Y. Síndrome post-COVIDen pacientes con enfermedad porcoronavirus. Rev cubana med [Internet].2022 [citado 18/05/2022];61(1):4-6. Disponibleen http://creativecommons.org/licenses/by-nc/4.0/deed.es_ES

  12. Díaz Y,Tejeda E, Díaz EG, SantiagoW, Oyarzabal A, Calderón N. Caracterizaciónclínica y epidemiológica depacientes con la COVID-19. Rev Cubanade Med Mil [Internet]. 2021 [citado18/05/2022];50(1):4-5. Disponible enhttp://www.revmedmilitar.sld.cu/index/php/revmedmilitar/article/view

  13. Muller MP, de Jager J, et al. One-yearoutcomes and health care utilization insurvivors of severe acute respiratory syndrome.Arch Intern Med [Internet]. 2020[citado 18/05/2022];167(12):1312-20.Disponible en https://archintermed.com/index/php/archintermed/article/view

  14. Tyagi SC, Singh M. Daño multiorgánicopor Covid-19: insuficiencia cardíacacongestiva (cardiopulmonar) yfuga de la barrera hemato-cardíaca.Rev corsalud [Internet]. 2021 [citado18/05/2022];476(4):1891-1895. Disponibleen https://www.revcorsalud.sld.cu/index/php/revcorsalud/article/view

  15. Farak Gómez J. Síndrome postCOVID 19 ¿de qué se trata? iMedPubJournals [Internet]. 2021 [citado18/05/2022];17(5):1. Disponible en https://www.archivosdemedicina.com/index/php/archivosdemedicina/article/view

  16. Huang C, Huang L, Wang Y, Li X, Ren L,Gu X et al. 6-month consequences of COVID-19 in patients discharged from hospital:a cohort study. Lancet [Internet] 2021[citado 18/05/2022];397(10270):220-232. Disponible en https://doi:10.1016/S0140-6736(20)32656-8

  17. Guler SA, Ebner L, Beigelman C, BridevauxPO, Brutsche M, Clarenbach C,et al. Pulmonary function and radiologicalfeatures four months after COVID-19: first results from the nationalprospective observational Swiss COVID-19 lung study. Eur Respir J [Internet].2021[citado 18/05/2022];25(1):9-12. Disponible en https://doi.org/10.1183/13993003.03690.2020

  18. Elias Armas KS, Pérez Mola K, BatistaCuenca M. El sistema cardiovasculary el daño inducido por el coronavirus 2.Rev cubana med [Internet]. 2021 [citado18/05/2022];60(2):4. Disponible enhttps://www.revmedicina.sld.cu/index/php/revmedicina/article/view

  19. Pérez Cabrera LA, Planas SliuntiaevaNL, Aroche Aportela R. Miocarditispost-Covid: a propósito de un caso tratadocon Jusvinza. Invest Medicoquir[Internet]. 2021 [citado 18/05/2022];13(supl.):2. Disponible en https://www.revcimeq.sld.cu/index/php/revcimeq/article/view

  20. Piñera-Castro HJ. COVID-19 y síndromede Guillain-Barré: ¿una relación fortuita?Rev mex neurocienc [Internet]. 2020[citado 18/05/2022];21(5):205-2014.Disponible en https://doi.org/10.24875/rmn.20000079

  21. Needham E, Newcombe V, MichellA, Thornton R, Grainger A, Anwar F,et al. Mononeuritis multiplex: an unexpectedlyfrequent feature of severeCOVID-19. J Neurol [Internet]. 2020 [citado18/05/2022];268: 2685–9. Disponibleen: https://link.springer.com/article/10.1007/s00415-020-10321-8




2020     |     www.medigraphic.com